Estrella Immunopharma Inc.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol ESLA:xnas
Currency USD
NASDAQ (Small cap)
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.047814624bn
Data provided by 
/ 
/